Nicolas I.
- Country
- France
- Department
- Medical Oncology
Research Overview
- Phase I/IIa Study of Inhaled CIS-DPI as Adjunctive Therapy in Stage IV Non-Small Cell Lung Cancer Patients
- Phase II Study of Durvalumab, Tremelimumab, and Olaparib in Solid Tumors with Homologous Recombination Repair Gene Mutations Post-Olaparib Response
- Phase I Study of XL092 Monotherapy and Combination Therapy in Advanced Solid Tumors: ccRCC, nccRCC, HR+ BC, mCRPC, and CRC
Data & Insights
Has run more than one trial at 456 of 818 partner sites.
Specializations
Sarcoma Research
The investigator specializes in treating various types of sarcomas, with particular focus on gastrointestinal stromal tumors (GIST) and soft tissue sarcomas.
- Leiomyosarcoma Treatment
- Osteosarcoma Management
- Advanced GIST Therapies
Their work encompasses both early-stage and metastatic sarcoma treatments, including novel therapeutic combinations.
Breast Cancer Studies
The investigator conducts extensive research in breast cancer treatment, particularly focusing on HER2-positive and hormone receptor-positive disease variants.
- Triple-Negative Breast Cancer
- Advanced Metastatic Disease
- Targeted Therapies
Their research includes innovative approaches in both early-stage and advanced breast cancer settings.
Advanced Solid Tumors
The investigator leads studies in various advanced solid tumors, exploring novel therapeutic approaches and combinations.
- Immunotherapy Applications
- Molecular Targeted Therapies
- Treatment-Resistant Cancers
Their work includes evaluating new therapeutic agents across multiple tumor types.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.